Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.

Suppr

超能文献

作者信息

Loehrer P J, Birch R, Kramer B S, Greco F A, Einhorn L H

出版信息

Cancer Treat Rep. 1986 Jul;70(7):919-20.

PMID:3013402

Abstract

摘要

相似文献

Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.

Cancer Treat Rep. 1986 Jul;70(7):919-20.

"Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".

Cancer Treat Rep. 1987 Apr;71(4):431-2.

Combination chemotherapy and radiation therapy in lung cancer.

Semin Oncol. 1994 Jun;21(3 Suppl 6):72-8.

Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.

Cancer Treat Rep. 1986 Jun;70(6):795-6.

[Possibilities of chemotherapy in patients with bronchial cancer].

Rontgenblatter. 1988 Mar;41(3):113-6.

[MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].

G Ital Chemioter. 1984 Jan-Aug;31(1-2):185-9.

[Taxol in bronchial carcinoma].

Med Klin (Munich). 1996 Dec 15;91 Suppl 2:1-6.

Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.

J Chemother. 1989 Jul;1(4 Suppl):1205-6.

Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.

Vet Hum Toxicol. 1981;23(Suppl 1):12-4.

[Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].

Med Clin (Barc). 1984 May 19;82(19):836-9.

引用本文的文献

The antioxidant N-acetylcysteine prevents HIF-1 stabilization under hypoxia in vitro but does not affect tumorigenesis in multiple breast cancer models in vivo.

PLoS One. 2013 Jun 20;8(6):e66388. doi: 10.1371/journal.pone.0066388. Print 2013.

Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy.

Cancer Invest. 2011 Dec;29(10):655-67. doi: 10.3109/07357907.2011.626479.

Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Cancer Chemother Pharmacol. 1988;21(2):89-102. doi: 10.1007/BF00257354.

Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity.

Invest New Drugs. 1988 Sep;6(3):239-41. doi: 10.1007/BF00175406.

Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer.

Cancer Chemother Pharmacol. 1990;26(5):369-72. doi: 10.1007/BF02897296.

Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors.

Invest New Drugs. 1992 Aug;10(3):159-63. doi: 10.1007/BF00877240.

New perspectives in lung cancer.5. New drugs in lung cancer.

Thorax. 1992 Mar;47(3):188-94. doi: 10.1136/thx.47.3.188.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验